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Abstract
Several researchers have described two-part models with patient-specific stochastic processes for
analysing longitudinal semicontinuous data. In theory, such models can offer greater flexibility
than the standard two-part model with patient-specific random effects. However, in practice the
high dimensional integrations involved in the marginal likelihood (i.e. integrated over the stochas-
tic processes) significantly complicates model fitting. Thus non-standard computationally intensive
procedures based on simulating the marginal likelihood have so far only been proposed. In this pa-
per, we describe an efficient method of implementation by demonstrating how the high dimensional
integrations involved in the marginal likelihood can be computed efficiently. Specifically, by using a
property of the multivariate normal distribution and the standard marginal cumulative distribution
function identity, we transform the marginal likelihood so that the high dimensional integrations
are contained in the cumulative distribution function of a multivariate normal distribution, which
can then be efficiently evaluated. Hence maximum likelihood estimation can be used to obtain
parameter estimates and asymptotic standard errors (from the observed information matrix) of
model parameters. We describe our proposed efficient implementation procedure for the standard
two-part model parameterisation and when it is of interest to directly model the overall marginal
mean. The methodology is applied on a psoriatic arthritis data set concerning functional disability.
Keywords
Semicontinuous data, two-part models, overall marginal mean, patient-specific inference, serial cor-
relation, psoriatic arthritis.
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1 Introduction
Semicontinuous data arise when the outcome is a mixture of true zeros and continuously distributed
positive values.1 Some examples in the literature have included average daily alcohol consumption,1
hospital lengths of stay2 and medical expenditures.3,4 In these situations, and more generally, it
is natural to view the outcome as a result of two processes, the first determines if the outcome is
zero, and if not the second determines the positive value. Two-part models are therefore convenient
for the analysis of semicontinuous data and have been used extensively. Recently, Smith et al.3,4
considered the interesting notion of reparameterising the mean of the positive values in terms of
the overall mean, which is arguably a more justified target of inference (see Tom et al.5 and the
references therein). We also consider this notion with respect to the overall marginal mean in our
framework.
Two-part marginal models and two-part mixed models have both been proposed for the anal-
ysis of longitudinal semicontinuous data. The first is motivated by obtaining population-based
inference and have been constructed using generalized estimating equations.6 The second is more
convenient when patient-specific inference is of interest, and are constructed by incorporating corre-
lated patient-specific random effects in both parts of the model.7 This paper focuses on the two-part
mixed modelling approach, although considerations are provided on how population-based infer-
ence can be obtained.
In some situations, correlated patient-specific random effects models will not provide an ade-
quate fit to the data. This may especially be the case when the lengths of follow-up are relatively
long. Here it may be less plausible to assume that patients can only have consistently high or low
outcomes throughout their entire follow-up. In terms of the correlation structure, it may not be
reasonable to assume constant correlation between outcomes from the same patient regardless of
their gap times (which is induced by patient-specific random effects). Flexible two-part models that
allow for random changes in the trajectory through serially correlated stochastic processes may then
be more plausible and these have been proposed in the literature. Albert and Shen8 and Ghosh
and Albert9 proposed two-part mixed models that consisted of correlated Gaussian processes and
random walks (in addition to correlated patient-specific random effects) respectively in both parts
of the model. Albert and Shen8 demonstrated, through their application and a simulation study,
that overall conditional means may suffer from bias if serial correlation (which is not captured
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by patient-specific random effects) is present but ignored. It is also worth noting, both models
incorporating stochastic processes provided considerable improvements of fit to their data.
A main drawback of fitting models with stochastic processes is the computationally intensive
nature of the model fitting procedure. The primary difficulty results from the following feature: if
a patient has mi observations, then a model consisting of correlated stochastic processes in each
part of the model will require 2mi integrations to evaluate the marginal likelihood contribution
from that patient (assuming, as is usual, the stochastic processes are realised at the observation
times). For manageable values of mi, Albert and Shen
8 and Ghosh and Albert9 have developed
methods based on a Monte Carlo Expectation Maximization algorithm and Markov chain Monte
Carlo respectively to evaluate the marginal likelihood. Both of these procedures can be compu-
tationally intensive, with the former also requiring standard errors of parameter estimates to be
computed by bootstrap. The primary aim of this paper is to demonstrate, using a property of
the multivariate normal distribution and the standard marginal cumulative distribution function
identity, how a marginal likelihood can be obtained in terms of the cumulative distribution func-
tion of a multivariate normal distribution. Implicitly, because it is possible to efficiently evaluate
the cumulative distribution function of a multivariate normal distribution, maximum likelihood
estimation can be used to obtain parameter estimates and (asymptotic) standard errors (from the
observed information matrix) of model parameters.
The rest of this paper is organised as follows. In Section 2, the motivating application concern-
ing functional disability in psoriatic arthritis is introduced. Section 3 describes the flexible two-part
modelling framework of Albert and Shen8 and Ghosh and Albert9 (including additional comments
regarding implementation). Section 4 proposes an efficient maximum likelihood estimation pro-
cedure for the models in Section 3. Section 5 applies the methodology in Section 4 to the data
described in Section 2. While retaining the flexibility of using stochastic processes models and the
practicality of the proposed efficient implementation procedure, Section 6 extends the modelling
framework of Section 3 to allow for the direct modelling of the overall marginal mean. Finally,
concluding remarks are made in Section 7.
3
2 Functional disability in psoriatic arthritis
Psoriatic arthritis (PsA) is an inflammatory arthritis associated with the skin condition psoriasis.
Because of both skin and joint involvement of the disease, PsA can result in patients having severe
physical functional disability. The dominant measure of functional disability in PsA, as well as
in many other disease areas,10 is the self reported Health Assessment Questionnaire (HAQ). This
produces an essentially continuous measure11−14 between zero, representing no disability, and three,
representing severe disability.
The HAQ scores of 698 patients observed longitudinally at the University of Toronto PsA clinic
was considered for this analysis. Figure 1 shows the frequencies of HAQ scores from these patients.
From Figure 1, it is evident that a large proportion of zeros exist in this data set (1526/4811=0.32).
The clumping at zero, together with the continuous distributed outcomes for the non-zero values,
suggests that the HAQ score can be viewed as a semicontinuous outcome. Su et al.12,13 considered
two-part models with patient-specific random effects for analysing an earlier version of this PsA
data set. In this paper, we relax the assumption of constant patient-specific random effects to
patient-specific stochastic processes and consider the extent to which they improve understanding
of the disability process. This includes making easy interpretable inference on the overall marginal
mean HAQ scores, a concept that has not been considered before with stochastic processes models
(see Section 6 for more details). On average, patients had 6.89 clinic visits (ranging from 2 to 20)
with mean inter-visit and follow-up times of 1 year and 5 months (standard deviation (SD) of 1
year and 1 month) and 8 years and 3 months (SD of 5 years and 10 months) respectively.
3 Model
Let Yij (i = 1, . . . , N) denote the semicontinuous response from patient i at time tij (j = 1, . . . ,mi),
where tij represents the time of the jth observation from patient i. Because of true zeros, it is
natural to decompose the response into
Uij =
 1 : Yij > 00 : Yij = 0
and g(Yij)|Yij > 0, where g(·) is a monotonic function such that g(0) = 0 and g(Yij)|Yij > 0 is
positive and approximately Gaussian with constant variance σ2. For convenience, the model for
4
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Figure 1: Frequencies of HAQ scores in our data
Uij is referred to as the binary component, while the model for g(Yij)|Yij > 0 is referred to as the
continuous component.
We now describe the flexible modelling framework. Let Xij and Zij be column vectors of co-
variates that influence the probability of Yij > 0 and the mean of g(Yij)|Yij > 0 respectively. Then
conditional on correlated patient-specific random effects (Bri = b
r
i , C
r
i = c
r
i ) and correlated stochas-
tic processes {Bsi (tij) = bsij , Csi (tij) = csij}, where the random effects are assumed independent of
the stochastic processes, we model Uij as Bernoulli with response probability
P(Uij = 1|bsij , bri ) = Φ(X>ijβ + bsij + bri ) (1)
where Φ(·) is the cumulative distribution function of a standard Gaussian distribution (i.e. probit
model), and [g(Yij)|Yij > 0; csij , cri ] as Gaussian with mean Z>ijγ+ csij + cri and constant variance σ2
(i.e. linear mixed effect model on g(Yij)|Yij > 0). Here β and γ are column vectors of regression co-
efficients. The patient-specific random effects (Bri , C
r
i ) allow patients to have a consistently high or
low probability of having disability and a consistently high or low mean for the non-zero HAQ scores
across time. While the patient-specific stochastic processes {Bsi (ti1),. . .,Bsi (timi),Csi (ti1), . . .,Csi (timi)}
can capture serial correlation and non-predictable changes in unobserved heterogeneity.9
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We assume {Bri , Cri } follows a bivariate normal distribution with mean vector zero and
Var(Bri ) = σ
2
b , Var(C
r
i ) = σ
2
c , Cov(B
r
i , C
r
i ) = σbσcρ (2)
where σ2b and σ
2
c are variance parameters and ρ is the correlation between B
r
i and C
r
i . Furthermore,
we consider two classes of stochastic processes for {Bsi (t), Csi (t)} that are subsequently described.
For convenience, define Bi(t) = B
r
i +B
s
i (t) and Ci(t) = C
r
i +C
s
i (t), i.e. the patient-specific random
effects Bri and C
r
i are absorbed into the stochastic processes Bi(t) and Ci(t) respectively, and let
the covariance matrix of {Bi(ti1),. . .,Bi(timi),Ci(ti1), . . .,Ci(timi)} be
Σi =
 Σib Σibc
Σibc Σic
.
3.1 Correlated Gaussian processes
The first and most general model that we consider is defined when {Bsi (t), Csi (t)} are correlated
stationary Gaussian processes. That is the model proposed by Albert and Shen:8
Cov{Bsi (tij), Bsi (tik)} = σ2gbρ|tij−tik|gb , Cov{Csi (tij), Csi (tik)} = σ2gcρ
|tij−tik|
gc , (3)
Cov{Bsi (tij), Csi (tik)} = σgbσgcρgρ|tij−tik|gbc
where σ2gb and σ
2
gc are variance parameters, ρg is the correlation between the Gaussian processes
at the same time point, and ρgb, ρgc, ρgbc are the degradation parameters governing the serial
correlation within and between processes respectively. Following Albert and Shen,8 the processes
Bi(t) and Ci(t) are taken to be exchangeable Ornstein-Uhlenbeck (EOU) processes, and the model
containing these processes is called the general model, i.e. (1-3). Some special cases of the general
model are
• Shared EOU process model when cij = θbij ,
• Correlated OU processes model when σ2b ≡ σ2c ≡ ρ ≡ 0,
• Shared OU process model when csij = θbsij and σ2b ≡ σ2c ≡ ρ ≡ 0,
• Correlated random effects model when σ2gb ≡ σ2gc ≡ ρg ≡ ρgb ≡ ρgc ≡ ρgbc ≡ 0,
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• Shared random effect model when cri = θbri and σ2gb ≡ σ2gc ≡ ρg ≡ ρgb ≡ ρgc ≡ ρgbc ≡ 0,
where θ is a parameter to be estimated.
3.1.1 Remarks on ρgb, ρgc and ρgbc
Although the general model is very flexible, it will not always be mathematically valid. Let the co-
variance matrices Σsib, Σ
s
ic and Σ
s
ibc have (j, k)th entry σ
2
gbρ
|tij−tik|
gb , σ
2
gcρ
|tij−tik|
gc and σgbσgcρgρ
|tij−tik|
gbc
respectively, i.e. described by (3). If ρgb, ρgc and ρgbc are unconstrained (as specified by Albert
and Shen8), the matrix Σsi where
Σsi =
 Σsib Σsibc
Σsibc Σ
s
ic

will not in general be a valid covariance matrix since Σsi , although symmetric, is not constrained to
be positive semi-definite and therefore Bsi (t) and C
s
i (t) will not necessarily form a jointly Gaussian
process. The primary difficulty results when ρg (the correlation between B
s
i (t) and C
s
i (t) at each
time t) is close to one because the processes Bsi (t) and C
s
i (t) are similar and therefore it will not
be plausible for them to degrade at vastly different rates (i.e. for ρgb, ρgc and ρgbc to be vastly
different). A reasonable approximation in this situation would be to constrain the degradation and
cross degradation parameters to be same, specifically ρgb ≡ ρgc ≡ ρgbc ≡ ρg1. This constraint would
then enforce Σsi to be a valid covariance matrix since the Schur component Σ
s
ib−Σsibc(Σsic)−1Σsibc ≡
σ2gb(1 − ρ2g)Σsi (ρg1), where Σsi (ρg1) has (j, k)th entry ρ|tij−tik|g1 , is constrained to be positive semi-
definite. The resulting correlation structure would then be
Cor{Bsi (tij), Bsi (tik)} = Cor{Csi (tij), Csi (tik)} = ρ|tij−tik|g1 , (4)
Cor{Bsi (tij), Csi (tik)} = ρgρ|tij−tik|g1 .
In the motivating application ρg was estimated close to one. Slight deviations from the correlation
structure described by (4) (for example ρgb ≡ ρgc ≡ ρg1 and ρgbc = ρg1δ where δ ∈ (0, 1)) resulted
in non-positive semi-definite matrices for various Σi, and therefore the model fitting procedure
was problematic. Note that a further simplification would be to constrain ρg = 1 (in addition to
ρg1 = ρgb), this would result in the shared EOU process model. If however ρg takes a smaller
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value, and therefore the two Gaussian processes are less correlated, it would then be more plausible
for the Gaussian processes to degrade at different rates. Hence having unconstrained degradations
parameters will likely be less problematic.
For completeness, note that
{Σib}jk = σ2b + σ2gbρ|tij−tik|gb , (5)
{Σic}jk = σ2c + σ2gcρ|tij−tik|gc ,
{Σibc}jk = σbσcρ+ σgbσgcρgρ|tij−tik|gbc .
3.2 Correlated random walks
The second model structure that we consider is defined when {Bsi (t), Csi (t)} are correlated continuous-
time random walks. That is the model proposed by Ghosh and Albert.9 Specifically, define sequen-
tially {Bi(tij+1), Ci(tij+1)}|{Bi(tij) = bij , Ci(tij) = cij} to be bivariate normal with mean (bij , cij)
and covariance matrix
 σ2wb(tij+1 − tij) σwbσwcρw(tij+1 − tij)
σwbσwcρw(tij+1 − tij) σ2wc(tij+1 − tij)
.
In addition (bi1, ci1) = (b
r
i , c
r
i ) are initiated at realisations of the patient-specific random effects.
Here σ2wb, σ
2
wc and ρw are variance and correlation parameters that quantify serial correlation (both
within and across processes). This model will be denoted by a correlated random walks (CRW)
model and it contains as special cases.
• Shared random walk model when cij = θbij ,
• Correlated random effects model when σ2wb ≡ σ2wc ≡ ρw ≡ 0,
• Shared random effect model when cri = θbri and σ2wb ≡ σ2wc ≡ ρw ≡ 0.
Although the CRW model is less flexible than the general model, it has the advantage, from its
sequential construction, of always being well defined even when the parameters are unconstrained
(apart from the usual constraint that correlation parameters have modulus less than or equal to
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unity). Moreover
{Σib}jk = σ2b + σ2wb{min(tij , tik)− ti1}, (6)
{Σic}jk = σ2c + σ2wc{min(tij , tik)− ti1},
{Σibc}jk = σbσcρ+ σwbσwcρw{min(tij , tik)− ti1}.
4 Efficient maximum likelihood estimation procedure for stochas-
tic processes models
This section describes our efficient maximum likelihood estimation procedure for the flexible mod-
els described in Section 3. Firstly, in Section 4.1 we describe a generic likelihood function for all
of the described models. The multivariate normal identity that can be used to evaluate certain
multi-dimensional integrals in terms of a multivariate normal cumulative distribution function is
introduced in Section 4.2. Finally, in Section 4.3 we outline how to apply the multivariate normal
identity in Section 4.2 to the generic likelihood function in Section 4.1, thus culminating in a com-
putationally efficient likelihood. For completeness, we also provide computational simplifications
for correlated stochastic processes models in the appendix.
4.1 Likelihoods
For ease of exposition, we describe the likelihood contribution from patient i. The likelihood can
then be obtained by taking the product of all likelihood contributions from each patient. Firstly, we
consider models that contain two (correlated) stochastic processes. For these models, the likelihood
contribution from patient i is
Li(Θ) =
∫
bi
∫
ci
mi∏
j=1
Φ(X>ijβ + bij)
uij{1− Φ(X>ijβ + bij)}1−uij
 (7)
×
mi∏
j=1
[
1√
2piσ2
exp
{
−(g(yij)−Z
>
ijγ − cij)2
2σ2
}]uijφ(2mi)(bi, ci; 0,Σi) dbi dci
where Θ is a vector representing all of the unknown parameters, bi = (bi1, . . . , bimi)
> and ci =
(ci1, . . . , cimi)
>, φ(m)(.;µ,Σ) is an m dimensional multivariate normal density with mean vector µ
and covariance matrix Σ, and Σi is defined by either (5) or (6). Similarly, for models containing a
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single stochastic process (i.e. shared process models), the likelihood contribution from patient i is
Li(Θ) =
∫
bi
mi∏
j=1
Φ(X>ijβ + bij)
uij{1− Φ(X>ijβ + bij)}1−uij
 (8)
×
mi∏
j=1
[
1√
2piσ2
exp
{
−(g(yij)−Z
>
ijγ − θbij)2
2σ2
}]uijφ(mi)(bi; 0,Σib) dbi
where Σib can again be obtained from (5) or (6). We now define our generic likelihood contribution
from patient i which encompasses all of the described models. Throughout we apply the following
notation: 0 and 1 are mi × 1 vectors with all entries being zero and one respectively, diag(v) is a
matrix with diagonal elements v and zero otherwise, and Id is a d × d identity matrix. We also
follow the convention that binary operations with a scalar and vector or matrix argument and
unary operations with a vector argument are performed element-wise. In matrix form, we have
Li(Θ) =
∫
li
Φ(mi) (Ai1µib +Ai2li; 0, Imi)
(
1√
2piσ2
)∑mi
j=1 uij
(9)
× exp
{
−(g(yi)−Ai3µic −Ai4li)
>(g(yi)−Ai3µic −Ai4li)
2σ2
}
φ{dim(li)}(li; 0,Σil) dli
where yi = (yi1, . . . , yimi)
>, µib = Xiβ, µic = Ziγ, Xi = (Xi1, . . . ,Ximi)>, Zi = (Zi1, . . . ,Zimi)>,
and Ai1 = diag(2ui − 1), Ai3 = diag(ui) are mi ×mi matrices with ui = (ui1, . . . , uimi)>. Here
Φ(d)(.; 0,Σ) represents the distribution function of φ(d)(.; 0,Σ) and li is a (to be specified) column
vector of random effects. Note that (9) has resulted from repeated application of the identity
1− Φ(x) = Φ(−x).
The likelihood contribution from patient i, Li(Θ), is then obtained by specifying the vector of
random effects li and its covariance matrix Σil together with the mi × dim(li) matrices Ai2 and
Ai4 which describe how the random effects act on the binary and continuous components of the
model. For (7), li = (bi, ci), Ai2 = (diag(2ui − 1),diag(0)) and Ai4 = (diag(0),diag(ui)). While
for (8), li = bi, Ai2 = diag(2ui − 1) and Ai4 = diag(θui). Similarly, for the correlated random
effects model, li = (bi, ci), Ai2 = (2ui − 1,0) and Ai4 = (0,ui), and for the shared random effect
model, li = bi, Ai2 = 2ui − 1 and Ai4 = θui.
4.2 Multivariate normal identity
In order to evaluate the likelihood described by (9), we derive a multivariate normal identity
that makes use of a property of the multivariate normal distribution and the standard marginal
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cumulative distribution function identity. Firstly, suppose that ω = (ω1,ω2)
> follows a multivariate
normal distribution with mean vector (0,η)> where ω1 and 0 are k1 × 1 vectors and ω2 and η
are k2 × 1 vectors respectively. Furthermore, suppose that the covariance matrix of ω is the
(k1 + k2)× (k1 + k2) matrix Σ where the first k1 rows of Σ is the k1 × (k1 + k2) matrix (Σ22,Σ>12)
and the remaining k2 rows of Σ is the k2×(k1+k2) matrix (Σ12,Σ11) respectively. It is a well known
result that φ(k1+k2)(ω; (0,η)>,Σ) = φ(k1)(ω1; Σ>12Σ
−1
11 (ω2−η),Σ22−Σ>12Σ−111 Σ12)φ(k2)(ω2;η,Σ11)
where the right-hand side is the product of the conditional density of ω1|ω2 and the marginal density
of ω2. By applying the standard marginal cumulative distribution function identity Fω1(ω1) =∫
ω2
Fω1|ω2(ω1|ω2)fω2(ω2) dω2 where the integrand is based on the right-hand side of the above
result, we obtain the multivariate normal identity:
Φ(k1)(ω1; 0,Σ22) =
∫
ω2
Φ(k1)
(
ω1 −Σ>12Σ−111 (ω2 − η); 0,Σ22 −Σ>12Σ−111 Σ12
)
φ(k2) (ω2;η,Σ11) dω2
(10)
by noting that the marginal distribution of ω1 is multivariate normal with mean vector 0 and
covariance matrix Σ22.
Returning to the application, the general idea is to rearrange (9) to take the form of the right-
hand side of (10), and then to use (10) to compute the integrations over the random effects in terms
of an mi dimensional normal cumulative distribution function. Because there exists efficient imple-
mentations of the multivariate normal cumulative distribution function, this approach will allow
for the efficient computation of the generic likelihood. We note that Barrett et al.15 used (10) to
obtain computationally efficient likelihoods of flexible models that jointly consider longitudinal and
time to event outcomes. Equation (10) also arises frequently in results concerning the multivariate
skew normal distribution16−19.
4.3 Re-expressing the likelihoods
This section demonstrates how (9) (the likelihood contribution from patient i) can be re-expressed.
We firstly consider the integrand terms resulting from the continuous component and random
effects. That is,(
1√
2piσ2
)∑mi
j=1 uij
exp
{
−(g(yi)−Ai3µic −Ai4li)
>(g(yi)−Ai3µic −Ai4li)
2σ2
}
φ{dim(li)}(li; 0,Σil).
(11)
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By completing the square in li (see the appendix for more details), (11) can be rearranged as
Li1φ
{dim(li)}(li;hi,H−1i ) (12)
where
Hi =A
>
i4Ai4/σ
2 + (Σil)
−1, (13)
hi =H
−1
i A
>
i4(g(yi)−Ai3µic)/σ2
and
Li1 =
(
1√
2piσ2
)∑mi
j=1 uij 1
|ΣilHi|1/2
exp
{
−(g(yi)−Ai3µic)
>(g(yi)−Ai3µic)
2σ2
+
h>i Hihi
2
}
(14)
is independent of li. Substituting (12) into (9), we consider the integral (ignoring Li1):∫
li
Φ(mi) (Ai1µib +Ai2li; 0, Imi)φ
{dim(li)}(li;hi,H−1i ) dli. (15)
We can re-express the argument and covariance matrix of the multivariate normal distribution
function in (15) as
Ai1µib +Ai2li = Ai1µib +Ai2hi − (−H−1i A>i2)>Hi(li − hi) (16)
Imi = Imi +Ai2H
−1
i A
>
i2 − (−H−1i A>i2)>Hi(−H−1i A>i2).
Therefore (15), after applying the multivariate normal identity (described by (10)), is equivalent to
Φ(mi)
(
Ai1µib +Ai2hi; 0, Imi +Ai2H
−1
i A
>
i2
)
. (17)
Based on the above expressions, the likelihood contribution from patient i can now be re-
expressed as
Li(Θ) =Φ
(mi)
(
Ai1µib +Ai2hi; 0, Imi +Ai2H
−1
i A
>
i2
)( 1√
2piσ2
)∑mi
j=1 uij
(18)
× 1|ΣilHi|1/2
exp
{
−(g(yi)−Ai3µic)
>(g(yi)−Ai3µic)
2σ2
+
h>i Hihi
2
}
where
Ai1 = diag(2ui − 1) (19)
Ai3 = diag(ui)
Hi = A
>
i4Ai4/σ
2 + (Σil)
−1
hi = H
−1
i A
>
i4(g(yi)−Ai3µic)/σ2
12
and Σil = Σi or Σib with Ai2 and Ai4 defined by the specified model.
From (18-19), it is now evident that evaluating the integrations involved in Li(Θ) reduces to
computing the cumulative distribution function of a multivariate normal distribution. This can be
performed efficiently, for example by using the R20 package mnormt21. The model fitting procedure
is then completed by maximizing the log-likelihood, for example by using the BFGS22 optimization
technique, to obtain parameter estimates and asymptotic standard errors (from the observed Fisher
information matrix) of model parameters.
5 Application: patient-specific inference
Using the estimation procedure described in Section 4, we demonstrate how patient-specific in-
ference on the probability of being disabled and the transformed mean HAQ score conditional on
disability can be obtained. Specifically, how a unit change in covariate values impacts these quan-
tities for any specific patient. We consider the covariate effects of the number of clinically damaged
joints (time-dependent), the number of actively inflamed joints (time-dependent), sex (coded as
1 for males and 0 for females), arthritis duration in years (time-dependent), and age at onset of
arthritis in years (standardise). Following Su et al.,12,13 no transformation was applied to the non-
zero HAQ scores, i.e. g(y) = y.
Initially models with two stochastic processes were fitted to the HAQ data. This resulted in
large estimated correlation parameters between the random effects (i.e. ρ ≈ 1) and stochastic
processes for both the correlated Gaussian processes and random walks cases (i.e. ρg and ρw ≈ 1).
These results therefore suggested a single stochastic process would be sufficient for describing the
data. The shared EOU model was then fitted. However the analysis provided evidence for model
over-parameterisation as σˆ2 appeared to converge at virtually zero and a positive-definite observed
Fisher information matrix could not be attained (even when a considerably smaller tolerance level
than the default was specified for the computation of multivariate normal probabilities). We there-
fore considered the shared random walk and OU process models, and for comparative purposes,
the shared random effect model. The models containing stochastic processes were fitted using the
likelihood described by (18-19), while the shared random effect model was fitted using numerical
integration (since only a single integration per patient is required). The same parameter estimates
13
for the shared random effect model were obtained when (18-19) were used in the model fitting
procedure.
Table 1 presents the results of the fitted models. Across the models, the covariate effects on
the mean conditional on disability are seen to be relatively similar as the confidence intervals gen-
erally overlap. In addition, the models are in agreement with regard to the association of each
covariate apart from arthritis duration. Arthritis duration is statistically significant in the shared
random effect model but is not statistically significant in the models that incorporate stochastic
processes. It is interesting to note that there are strong agreements regarding the covariate effect
of the number of active joints (similar parameter estimates across models and relatively narrow
confidence intervals). The models indicate an additional actively inflamed joint will increase the
mean HAQ score conditional on disability by approximately 0.21 for any specific patient. For the
binary component, the covariate effects are again seen to be relatively similar due to the overlap-
ping confidence intervals. Their interpretation through the direction of association and statistical
significance are also consistent across models. The covariate effects from the shared random effect
model does however consistently demonstrate attenuation to the null when compared to the other
models with stochastic processes.
A generalized likelihood ratio test of σ2wb = 0 and ρgb = 1 produced p values of < 0.001 therefore
suggesting preference towards the shared random walk and OU process models respectively when
compared to the shared random effect model. Since the shared random walk and OU process models
contain the same number of parameters, information criteria, such as AIC, would indicate (weakly)
that the shared random walk model is preferable. It is also worth noting that the heterogeneity
parameter in the binary component (i.e. σ2b or σ
2
gb) is significantly lower in the shared random
effect model. For this model, this parameter governs both the heterogeneity and correlation due to
repeated measurements and therefore in light of greater unaccounted heterogeneity (compared to
the models with stochastic processes), less correlation is expected.23 In the continuous component,
where σ2 also accounts for heterogeneity, a smaller difference between the heterogeneity parameters
(i.e. θ2σ2b or θ
2σ2gb) is seen; in the order of the models displayed in the table (from right to left),
the heterogeneity parameters are 0.24, 0.36 and 0.25 respectively.
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6 Modelling the overall marginal mean
In many cases, it is of interest to obtain population-based inference in addition/as opposed to
patient-specific inference. For example, for strategic public health policy purposes it would be
more clinically meaningful to obtain covariate effects on quantities of interest after averaging over
all patients. Currently, the proposed models are parametrised to allow easily interpretable patient-
specific covariate effects, those with Bi(tij) = bij and Ci(tij) = cij , to act on the patient-specific
mean of the transformed positive values (i.e. E[g(Yij)|Yij > 0, Ci(tij) = cij ]) and the patient-
specific probability of a having a positive value (i.e. P(Uij = 1|Bi(tij) = bij)). However, under this
parametrisation, it no longer becomes straightforward to obtain easily interpretable population-
level covariate effects on the marginal mean of the transformed positive values (the mean of the
transformed positive values after averaging over all bij and cij , i.e. E[g(Yij)|Yij > 0]) since it is a
highly non-linear function of the linear predictors in the binary and continuous components.5 Thus
the effect of a single covariate is generally interpreted by fixing other covariates at certain values.8
This problem remains even when population-level covariate effects on the overall marginal mean
of the transformed values (i.e. E[g(Yij)]) are of primary interest, which has strongly been argued
as an important target of inference;24 it is estimated using data from the same patients over time
(unlike E[g(Yij)|Yij > 0]) and it is a measure of the undecomposed outcome. We reiterate that in
considering the overall marginal mean of the transformed values as a target of inference, we assume
that the monotonic transformation function is such that g(0) = 0 and g(Yij)|Yij > 0 is positive and
approximately Gaussian with constant variance σ2.
In order to obtain population-based inference on the overall marginal mean of the transformed
values, Smith et al.4 proposed the following model parameterisation
P(Uij = 1|Bri = bri ) = g1(X>ijβ + bri ) (20)
E[g(Yij)|Cri = cri ] = g2(Z>ijα+ cri )
where g1(·) and g2(·) are monotonic link functions and Bri , Cri are, as before, zero mean bivariate
normal patient-specific random effects. Recall that transformation and link functions differ in that
transformation functions are applied prior to modelling. In their specific context, Smith et al.4
considered the identity transformation for g(·) but allowed the positive values of Yij to follow a
log-skew-normal distribution. Under this parametrisation, for a suitably chosen link function such
16
as g−12 being the identity or log link, it is implicit that easily interpretable covariate effects on the
overall marginal mean of g(Yij), α, can now be obtained. Smith et al.
4 implemented this model by
using a Bayesian estimation approach with
E[g(Yij)|Yij > 0, Bri = bri , Cri = cri ] =
g2(Z
>
ijα+ c
r
i )
g1(X>ijβ + b
r
i )
specified in the likelihoods defined by (7) or (8). Note that E[g(Yij)|Yij > 0, Bri = bri , Cri = cri ] is no
longer parametrised to be equivalent to a monotonic function of a linear predictor, as was specified
before. While this approach for modelling the overall marginal mean is intuitive, it is clear that
the multivariate normal identity in Section 4.2 can no longer be used to compute the integrations
over the multi-dimensional random effects in the marginal likelihood. Thus, as mentioned in the
introduction, implementation of such models can be computationally challenging, especially for
our situation where it would be of interest to consider bij and cij (i.e. realisations of stochastic
processes) instead of bri and c
r
i (i.e. realisations of patient-specific random effects) in (20).
We now propose another method which would allow easily interpretable covariate effects to
act on the overall marginal mean of g(Yij). In contrast, this method facilitates the inclusion of
stochastic processes because it retains the proposed efficient implementation procedure described
in Section 4. To the best of our knowledge, there are no other methods in the literature that
facilitates the practical implementation of stochastic processes models for directly modelling the
overall marginal mean.
We first begin by computing the overall marginal mean of g(Yij) when
P(Uij = 1|Bi(tij) = bij) = g1(X>ijβ + bij) (21)
E[g(Yij)|Yij > 0, Ci(tij) = cij ] = ∆ij + cij
where ∆ij is a function of covariates (at the jth visit from patient i) and regression coefficients
only. That is cij is now assumed to act linearly on the mean of the transformed positive values
and not on the overall mean of the transformed values as is the case in (20). For models with two
processes, the overall marginal mean of g(Yij) is defined by
E[g(Yij)] =
∫
b
∫
c
Φ(X>ijβ + bij)(∆ij + cij)φ
(2)(bij , cij ; 0,Σij) dbij dcij
17
where
Σij =
 σ2bij σbijσcijρbcij
σbijσcijρbcij σ
2
cij

and σ2bij , σ
2
cij and ρbcij are the variances and correlation of Bi(tij) and Ci(tij) respectively. Similarly,
the overall marginal mean for a shared process model is given by
E[g(Yij)] =
∫
b
Φ(X>ijβ + bij)(∆ij + θbij)φ
(1)(bij ; 0, σ
2
bij) dbij .
Conveniently, these integrals can be computed analytically and this results in
Φ
 X>ijβ√
1 + σ2bij
∆ij + σbijσcijρbcij√
1 + σ2bij
φ
 X>ijβ√
1 + σ2bij

and
Φ
 X>ijβ√
1 + σ2bij
∆ij + θσ2bij√
1 + σ2bij
φ
 X>ijβ√
1 + σ2bij

respectively. The derivation of the first overall marginal mean of g(Yij) (resulting from models with
two processes) can be found in the supplementary material of Tom et al.,5 and the second overall
marginal mean of g(Yij) is derived in the appendix. If we specify E[g(Yij)] = Z>ijα, we can then
reparametrise
∆ij =
Z>ijα− σbijσcijρbcij√
1 + σ2bij
φ
 X>ijβ√
1 + σ2bij
/Φ
 X>ijβ√
1 + σ2bij
 (22)
and
∆ij =
Z>ijα− θσ2bij√
1 + σ2bij
φ
 X>ijβ√
1 + σ2bij
/Φ
 X>ijβ√
1 + σ2bij

in the respective models. Thus, as in (20), α offers easily interpretable covariate effects of Zij on
the overall marginal mean of g(Yij) (by definition). In particular, a unit change in components of
Zij will increase the overall marginal mean of g(Yij) by the respective components in α. However,
from (21-22), it is also evident that replacing Z>ijγ with ∆ij in Section 4 will still allow the proposed
efficient estimation procedure to be applied. It is also possible to reparametrise patient-specific co-
variate effects β in the binary component in terms of population-level covariate effects ξ, specifically
β = ξ
√
1 + σ2bij , since it can be shown that P(Uij = 1) = Φ(X
>
ijβ/
√
1 + σ2bij). This relationship is
18
easily proved. In the motivating application, this reparametrisation led to a numerically unstable
optimization routine, therefore (β,α) was estimated with ξˆ obtained as βˆ/
√
1 + σˆ2bij and standard
errors were calculated using the delta method.
6.1 Population-based inference
Using the parameterisations described in the previous subsection, we demonstrate how population-
based inference on the probability of being disabled and the overall marginal mean HAQ score
can be obtained. Specifically, on averaging across patients, how a unit change in covariate values
impacts these quantities. For illustrative purposes, the same covariates as those considered in
the patient-specific case are considered. Note that for generalized linear models, conditional and
marginal covariate effects will generally differ unless certain random effects distributions and link
functions are chosen.25
As mentioned, marginal covariate effects on the probability of being disabled, ξ, were obtained
from β/
√
1 + σ2bij with β and σ
2
bij (the variance of Bi(tij)) estimated using the model fitting
procedure. The shared OU process and random effect models, where σ2bij does not depend on
j (or i) for these models, were considered. For models with random walks, σ2bij varies with j
and therefore ξ will have a time-dependent interpretation. For simplicity, these models are not
considered. The shared random effect model was fitted using the parameterisation described by
(20), with g1(y) = Φ(y) and g2(y) = y, and using the parameterisation described by (21-22), thus
the same link functions are used and the inferences (at the population-level) from these models are
comparable. These models will be denoted as shared random effect model-overall and -conditional
respectively. Note that unlike at the population-level, the patient-specific assumptions from the
shared random effect model-overall and -conditional are vastly different. The shared random effect-
overall model assumes that the overall patient-specific mean, i.e. E[Yij |Bri = bri , Cri = cri ], has a
linear form, namely Z>ijα + c
r
i . While the shared random effect-conditional model assumes that
this quantity takes a particular non-linear form, namely (∆ij + c
r
i )Φ(X
>
ijβ + b
r
i ). As before, the
shared random effect models (both -overall and -conditional) were fitted using numerical integration
and maximum likelihood estimation under the assumption that the positive values follow a normal
distribution with constant variance.
19
Table 2 presents the results. Population-level covariate effects on the overall marginal mean are
seen to be relatively similar across models due to the considerable overlap in confidence intervals.
All three models are in strong agreement regarding the population-level covariate effect of the
number of active joints. That is, on average, patients with an additional actively inflamed joint has
an overall mean HAQ score increased by approximately 0.02. In contrast to the patient-specific case,
the population-level covariate effects on the probability of being disabled are now more consistent
across models. A generalized likelihood ratio test of ρgb = 1 produced a p value of < 0.001 and
therefore the shared OU process model is to be preferred over the shared random effect-conditional
model. Log-likelihood values also indicate slight preference to the shared random effect-conditional
model (-3507.63) over the shared random effect-overall model (-3582.78).
7 Discussion
This paper reconsiders the flexible two-part models of Albert and Shen8 and Ghosh and Albert,9
and proposes an efficient method of implementation. Specifically, the problem of integrating over
high dimensional random effects is replaced by evaluating the cumulative distribution function of a
multivariate normal distribution. This leads to efficient algorithms being employed and results in
only an optimization procedure being required for model fitting. Furthermore, while retaining the
flexibility of including stochastic processes and the practicality of an efficient model fitting proce-
dure, this paper also provides model parameterisations which allow easily interpretable covariate
effects to act on the overall marginal mean. The proposed methodology was applied to a psoriatic
arthritis data set with extensive follow-up information.
Through their application and a simulation study, Albert and Shen8 demonstrated that overall
conditional means (conditional on realisations of stochastic processes) may suffer from bias if se-
rial correlation is present but a shared random effect model is used instead. Furthermore, as the
shared random effect model becomes more misspecified (ρgb decreases from one) the degree of bias
increases. However, under the same set-up, overall marginal means were less susceptible to bias.
In the motivating application, the estimated degradation parameters from the shared OU process
models were ρˆgb = 0.95 in both applications (Sections 5 and 6.1). The reasonably high estimated
correlation may therefore explain why the shared random effect model (ρgb = 1) was a reasonable
approximation in terms of estimating regression coefficients, although it was substantially the worst
20
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fitting model.
Preliminary analyses suggested shared process models were reasonable for our data since ρˆ, ρˆw
and ρˆg ≈ 1 when the described bivariate processes models were fitted. Although this may not be
surprising as both parts of the model are describing the same response process, it is worth noting
that the estimated correlation parameter (between processes) can in principle take a value between
(−1, 1) as evidenced in other works.7,9 Our preliminary analyses also demonstrated the need for
careful evaluation of models fitted as problems with over fitting may arise. This was evident when
the estimated random variation parameter was estimated to be virtually zero (i.e. σˆ2 ≈ 0) and the
observed Fisher information matrix was non positive-definite, even when a considerably smaller
tolerance level than the default was specified for computing multivariate normal probabilities.
As mentioned in Section 6, the proposed model parameterisations were motivated by making
inference on the overall marginal mean. In this regard, covariate effects (both patient-specific and
population-level) on the mean of the positive values and its correlation structure were assumed not
of interest. If the mean of the positive values is of primary interest, it would be more sensible to
directly use (18-19), as in Section 5, to obtain patient-specific effects or derive a similar parame-
terisation, as in Section 6, to obtain population-level effects.
A limitation of the current framework is that it is based on the assumption g(Yij)|Yij > 0 is
approximately Gaussian with constant variance σ2. Specifically, in situations where g(·) is required
to be complex so that this assumption will at least approximately hold, the resulting inferential
targets will no longer be intuitively interpretable owing to the complexity of the transformation
function. One approach that may weaken the need to assume normality of g(Yij)|Yij > 0, partic-
ularly when the outcome exhibits a large amount of right skewness (e.g. medical expenditures),
would be to make the alternative assumption g(Yij)|Yij > 0 follows a log-normal distribution. This
may allow less complex and hence more interpretable transformation functions to be applied to the
outcome without having to strongly violate the assumption on g(Yij)|Yij > 0. Under this alter-
native assumption, we provide details in the supplementary materials of how easily interpretable
inference on the overall marginal mean and on the mean of the positive transformed outcomes can
be obtained with computationally efficient likelihoods. Similar techniques to those in the supple-
mentary materials can also be used when the assumption g(Yij)|Yij > 0 follows a log-skew-normal
distribution is of interest. Although this comes at the cost of having an increased number of inte-
22
grations in the marginal likelihood.
Finally, the model described by (18-19) with possible simplifications described in Appendix B
is very general. Although it was derived in the context of longitudinal semicontinuous data, it
contains the model described by Barrett et al.19 for the longitudinal and survival outcomes set-
ting and implicitly provides a model for clustered cross-sectional semicontinuous data, where the
index (i, j) specifies the jth outcome from the ith cluster. The multivariate normal identity de-
scribed in Section 4.2 can also facilitate the fitting of flexible models describing clustered binary
data and continuous bounded outcome data14. However, it should be noted that care is required
when specifying an appropriate/suitable correlation structure. Particularly, the covariance matrix
must be constrained to be symmetric and positive semi-definite otherwise the model fitting proce-
dure will likely be problematic, as was found here. For these alternative situations, the proposed
methodology does nevertheless offer a strong basis, especially with regard to implementation, for
the developing of flexible models.
Appendix A Rearranging (11)
The continuous and random effects component in the integrand of (9) is(
1√
2piσ2
)∑mi
j=1 uij
exp
{
−(g(yi)−Ai3µic −Ai4li)
>(g(yi)−Ai3µic −Ai4li)
2σ2
}
φ{dim(li)}(li; 0,Σil).
We rearrange this expression by completing the square in li. This results in(
1√
2piσ2
)∑mi
j=1 uij
exp
{
−(g(yi)−Ai3µic)
>(g(yi)−Ai3µic)
2σ2
} |H−1i |1/2
|Σil|1/2
1
(2pi)dim(li)/2|H−1i |1/2
(23)
× exp
(
− l
>
i Hili
2
+ l>i Hihi
)
.
Focusing on terms containing li, we have
exp
(
− l
>
i Hili
2
+ l>i Hihi
)
= exp
{
−(li − hi)
>Hi(li − hi)
2
+
h>i Hihi
2
}
. (24)
Equation (12-14) now follows by substituting (24) into (23).
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Appendix B Simplification for correlated stochastic processes model
For the models containing correlated stochastic processes (described by (7)), recall that Σil = Σi
(where Σi is described by either (5) or (6)), Ai2 = (diag(2ui−1),diag(0)) and Ai4 = (diag(0),ui)
are mi × 2mi matrices. Simplification of (18) for this model structure is possible, specifically the
following (to be derived) equations:
Ai2hi =
(
Σuibc −Σuibc(Imi + Σuic/σ2)−1Σuic/σ2
)
(g(yi)−Ai3µic)/σ2 (25)
Ai2H
−1
i A
>
i2 = Σ
u
ib −Σuibc(Imi + Σuic/σ2)−1Σuibc/σ2
|ΣiHi| = |Σicdiag(ui)/σ2 + Imi |
h>i Hihi = (g(yi)−A3µic)>(Σuic −Σuic(Imi + Σuic/σ2)−1Σuic/σ2)(g(yi)−Ai3µic)/σ4
where
Σuib = diag(2ui − 1)Σibdiag(2ui − 1)
Σuic = diag(ui)Σicdiag(ui)
Σuibc = diag(2ui − 1)Σibcdiag(ui)
reduce the dimension of the respective matrix calculations (from 2mi to mi dimensional).
In order to derive the equations in (25), we begin by simplifying ΣiHi. That is
ΣiHi = ΣiA
>
i4Ai4/σ
2 + I2mi
=
 Σib Σibc
Σibc Σic

 diag(0) diag(0)
diag(0) diag(ui)/σ
2
+ I2mi
=
 Imi Σibcdiag(ui)/σ2
diag(0) Σicdiag(ui)/σ
2 + Imi
.
It now follows that
|ΣiHi| = |Imi ||Σicdiag(ui)/σ2 + Imi | = |Σicdiag(ui)/σ2 + Imi |.
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Next, we simplify h>i Hihi = (g(yi) − Ai3µic)>Ai4H−1i A>i4(g(yi) − Ai3µic)/σ4. By using the
Woodbury matrix identity, specifically
H−1i = Σi −ΣiA>i4(Imi +Ai4ΣiA>i4/σ2)−1Ai4Σi/σ2
and noting that
Ai4ΣiA
>
i4 = diag(ui)Σicdiag(ui) ≡ Σuic,
we have
h>i Hihi = (g(yi)−Ai3µic)>Ai4H−1A>i4(g(yi)−Ai3µic)/σ4
= (g(yi)−Ai3µic)>(Σuic −Σuic(Imi + Σuic/σ2)−1Σuic/σ2)(g(yi)−Ai3µic)/σ4.
To simplify Ai2hi, consider
Ai2hi = Ai2H
−1
i A
>
i4(g(yi)−Ai3µic)/σ2
=
(
Ai2ΣiA
>
i4 −Ai2ΣiA>i4(Imi + Σuic/σ2)−1Σuic/σ2
)
(g(yi)−Ai3µic)/σ2.
By noting that
Ai2ΣiA
>
i4 = diag(2ui − 1)Σibcdiag(ui) ≡ Σuibc,
we have
Ai2hi =
(
Σuibc −Σuibc(Imi + Σuic/σ2)−1Σuic/σ2
)
(g(yi)−Ai3µic)/σ2.
Furthermore
Ai2H
−1
i A
>
i2 = Σ
u
ib −Σuibc(Imi + Σuic/σ2)−1Σuibc/σ2
where
Σuib ≡ Ai2ΣiA>i2 = diag(2ui − 1)Σibdiag(2ui − 1).
Appendix C Overall marginal mean of shared process model
To obtain the overall marginal mean of a shared process model, the following integral must be
evaluated∫
b
Φ(X>β + b)(Z>γ + θb)φ(1)(b; 0, σ2b ) db =Z
>γ
∫
b
Φ(X>β + b)φ(1)(b; 0, σ2b ) db (26)
+θ
∫
b
bΦ(X>β + b)φ(1)(b; 0, σ2b ) db.
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The first term in (26) can be evaluated using the skew normal result, i.e. using (10), that is
Z>γ
∫
b
Φ(X>β + b)φ(1)(b; 0, σ2b ) db = Z
>γΦ(1)(X>β; 0, 1 + σ2b ) = Z
>γΦ
 X>β√
1 + σ2b
 .
To compute the second term in (26), consider
θ
∫
b
bΦ(X>β + b)φ(1)(b; 0, σ2b ) db = θσb
∫
b∗
b∗Φ(X>β + σbb∗)φ(b∗) db∗.
This integral can be computed using equation (10, 011.3) in Owen,26 which results in
θσ2b√
1 + σ2b
φ
 X>β√
1 + σ2b
 .
The overall marginal mean now follows.
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